| AKARI THERAPEUTICS ADR |
| USA |
| Gesundheit |
| US00972G2075 / A3ESDF |
| CLA (Frankfurt) / AKTX (NASDAQ) |
| FRA:CLA, ETR:CLA, CLA:GR, NASDAQ:AKTX |
| - |
| https://www.akaritx.com/ |
|
Akari Therapeutics Plc ADR represents American Depositary Receipts of Akari Therapeutics Plc, a biopharmaceutical company involved in the discovery and development of innovative treatments for rare an..
>Volltext.. |
| 5.85 Mio. EUR |
| 5.48 Mio. EUR |
| - |
| -11.4 Mio. EUR |
| -13.63 Mio. EUR |
| - |
| 1.83 Mio. EUR |
| 2.2 Mio. EUR |
| -8.39 Mio. EUR |
| 0.16 |
| - |
| -57.07% |
| - |
| - |
| - |
| - |
| AKARI THERAPEUTICS, AKARI THERAPEUTIC |
| 18.03.26 |
|